Saudi fencing talent Yusuf Al Duhainam dies
The Saudi Food and Drug Authority has announced the approval of the registration of the medication "Fondaio" for the treatment of obesity and weight gain associated with health risk factors. This comes as part of its efforts to combat obesity and improve public health, as the medication is used to treat obesity cases linked to health problems such as high blood pressure and diabetes. It is noted that the approval follows the completion of the necessary studies and trials, aiming to provide an effective treatment option for patients suffering from health risk factors related to obesity.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)